PROBENECID | A083740 | IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Amendment to Suitability Petition from Rising Pharma Holdings, Inc. FDA-2025-P-5431 · 9 docket documents Rising Pharma Holdings, Inc. filed this amendment to suitability petition FDA-2025-P-5431 on November 11, 2025, responding to an FDA information request by submitting proposed product labeling for Probenecid Tablets USP 250 mg pursuant to 21 CFR 314.93(d) in order for the FDA to complete review of R | Suitability | 2025-11-12 | Open | Rising Pharma Holdings, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
No patent or exclusivity listings for this strength.